142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

CVS's Landmark Decision to Stop Tobacco Sales: Rationale, Preparation for Implementation, and Current Experience

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014 : 12:50 PM - 1:10 PM

Eileen H. Boone, MBA , President of the CVS Caremark Charitable Trust, CVS Caremark, Woonsocket, RI
Smoking is the leading cause of premature disease and death in the United States with more than 480,000 deaths annually. That’s why CVS Caremark believes that tobacco products have no place in a setting where health care is delivered and this past February, they announced that they would stop the sale of all tobacco products at their more than 7,600 CVS/pharmacy locations across the country.  They are the first national retail pharmacy chain to take this step in support of the health and well-being of their customers.

Hear from Eileen Howard Boone, SVP of Corporate Social Responsibility and Philanthropy at CVS Caremark, who had a seat at the planning table for this major initiative. Eileen will discuss why the company made this decision, despite the estimated $2 Billion loss the company would take by exiting this category. She will also discuss the communications strategy behind the “CVS Quits” initiative, and how this announcement reignited the conversation around smoking in the United States, and had everyone from the President of the United States to the heads of the American Public Health Association, American Lung, American Cancer and American Heart Associations applauding this move.  Finally, she’ll explain the company’s plan to continue helping people lead tobacco free lives with the launch of a new cessation program this Fall.

Learning Areas:

Public health or related public policy

Learning Objectives:
Identify benefits of no tobacco sales in pharmacies; Define the health risks of smoking that CVS Caremark identified as the driving force behind their decision to stop selling tobacco products; and Analyze the pros and cons that this decision had on CVS Caremark as a business and as a health care provider.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Eileen received her MBA from Fordham University in marketing and finance. As Senior Vice President of Corporate Social Responsibility and Philanthropy at CVS Caremark she participated in development and implementation of the policy decisions discussed in this session. Eileen served as keynote speaker at the 2014 PR News CSR Awards Luncheon, and as a panelist for UMass Boston Center for Collaborative Leadership Forum, the Massachusetts Conference for Women, and the Fordham Women in Business Conference.
Any relevant financial relationships? Yes

Name of Organization Clinical/Research Area Type of relationship
CVS Caremark Social Responsibility & Philanthropy Employment (includes retainer)

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.